The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sucheta Dhruvkumar Jani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250 and 5.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sucheta Dhruvkumar Jani, part of the promoter/promoter group of Global Longlife Hospital and Research Ltd (BSE: 543520), sold 4,07,000 equity shares in the open market between December 23 and December 24, 2025. This represents 3.88% of the company's total share and voting capital. Her holding dropped from 6.29% (6,60,000 shares) to 2.41% (2,53,000 shares) after the sale. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations, which is triggered when a promoter or major shareholder crosses the 2% creeping acquisition/sale threshold. The total equity share capital remains Rs. 10.5 crore (1.05 crore shares of Rs. 10 each).
This is a notable promoter exit, reducing her stake by more than half (from 6.29% to 2.41%) in just two trading sessions. Retail investors may view this as a negative signal, as significant open-market selling by a promoter can weigh on short-term sentiment and raise concerns about insider outlook on the stock.